Rua Bioscience Limited logo

Unconditional sales contract of Rua manufacturing facility

Operational Update30 October 2024RUAHealthcare

PO Box 1387, Gisborne 4040, Aotearoa New Zealand | 0800 RUABIO | www.ruabio.com




FOR PUBLIC RELEASE

NZX Limited

Wellington


31

st

October 2024


Update: Unconditional sales contract of Rua manufacturing facility


At the time of this release Rua Bioscience has not received the settlement funds from the

the purchaser, Awa Ora Genesis Kaitiaki Harakeke Trust of Te Araroa, for the purchase of

the Gisborne manufacturing facility.


The contract is for $1.3 mill and was due to be paid in full by 5pm yesterday, 30th

October 2024.


The Board have received assurances from the Trust that they intend to complete the

purchase of the property and have requetsed further time before settlement.


The Board is now considering their legal options in this situation and are also in parallel

working with other credible parties on an alternate purchase plan.


The Board will update the market as soon as new information is received.



ENDS  


The person who authorised this announcement:


Paul Naske

Chief Executive Officer

paul.naske@ruabio.com

+64 21 445154


MARKET UPDATE

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.